Foundations Investment Advisors LLC Reduces Stake in IQVIA Holdings Inc. (NYSE:IQV)

Foundations Investment Advisors LLC lessened its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 2.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,775 shares of the medical research company’s stock after selling 159 shares during the period. Foundations Investment Advisors LLC’s holdings in IQVIA were worth $1,135,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Capital Performance Advisors LLP acquired a new position in shares of IQVIA in the 3rd quarter valued at about $27,000. Park Place Capital Corp acquired a new position in IQVIA in the third quarter valued at approximately $28,000. Avior Wealth Management LLC boosted its position in IQVIA by 117.6% in the 3rd quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock worth $38,000 after purchasing an additional 87 shares in the last quarter. Assetmark Inc. grew its stake in shares of IQVIA by 612.5% during the 3rd quarter. Assetmark Inc. now owns 228 shares of the medical research company’s stock worth $54,000 after purchasing an additional 196 shares during the period. Finally, UMB Bank n.a. increased its holdings in shares of IQVIA by 74.4% during the 3rd quarter. UMB Bank n.a. now owns 232 shares of the medical research company’s stock valued at $55,000 after purchasing an additional 99 shares in the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

IQVIA Stock Down 1.6 %

NYSE IQV opened at $203.59 on Wednesday. The business’s fifty day simple moving average is $200.02 and its 200-day simple moving average is $221.09. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. The firm has a market cap of $36.95 billion, a PE ratio of 26.72, a P/E/G ratio of 2.14 and a beta of 1.48. IQVIA Holdings Inc. has a 52 week low of $187.62 and a 52 week high of $261.73.

Wall Street Analysts Forecast Growth

IQV has been the topic of several analyst reports. Redburn Atlantic assumed coverage on shares of IQVIA in a research report on Monday, October 14th. They set a “buy” rating and a $276.00 price target on the stock. Truist Financial cut their price target on IQVIA from $265.00 to $261.00 and set a “buy” rating for the company in a research note on Thursday, December 12th. TD Cowen dropped their price objective on IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a report on Friday, November 1st. The Goldman Sachs Group reduced their target price on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, StockNews.com cut shares of IQVIA from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $255.71.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.